Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Y-mAbs Therapeutics, Inc. Financials Banner

Y-mAbs Therapeutics, Inc. Financials

YMAB Stock Analysis

Page title

Section title

YMAB Income Statement Key Metrics

  • Revenue(TTM)86.55 M
  • Gross Profit(TTM)76.70 M
  • EBITDA(TTM)-27.17 M
  • Net Income(TTM)-24.61 M
  • EPS Diluted(TTM)-0.5626

Decode YMAB's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

YMAB earnings and revenue history

YMAB Return on Equity

See how efficiently YMAB generates profit for it's shareholders.

-21.22%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity Growth

YMAB's Return on Equity has shown poor growth over the past 10 years, increasing by only -21.11%.

YMAB Revenue Growth

See how YMAB has grown it's revenue over the past 10 years.


Revenue Growth

YMAB's revenue has grown significantly over the past 10 years, increasing by over 0%.

YMAB FY, 2023 Revenue Breakdown

See how YMAB converts it's revenue into profit.

YMAB Balance Sheet Health

YMAB Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

YMAB financial position analysis

Short Term Liabilities

YMAB's short term assets($111M) can safely cover it's short term liabilities($20M).

Long Term Liabilities

YMAB's short term assets($111M) can safely cover it's long term liabilities($7M).

YMAB Debt to Equity